The affected product is the drugmaker’s clotrimazole and betamethasone dipropionate cream with an expiration date of March 2020.
Customers have complained that the cream is too wet or too gritty. Glenmark blamed the problem on temperature-control issues.
The recall is a Class 3, used when the affected product is not likely to cause adverse health consequences.
More articles on pharmacy:
FDA approves AbbVie’s $59K rheumatoid arthritis drug
Teva launches generic version of EpiPen for kids
American Regent boosted price of essential hospital product by 1,300%
